Despite this apparent functional complexity, RHAMM is an attractive therapeutic target due to its restricted homeostatic expression predicting a good safety profile, its association with a poor outcome in most cancers, and its critical functions that promote inflammation and fibrosis [12,62], which exacerbate cancer progression [130]. Here, HMMR is linked to cancer.